Some drugs may seem like they were named by throwing darts at the alphabet – but the process of drug naming is actually very intentional.
In an interview with Fox News Digital, Dr. Dave Latshaw, CEO of the AI health care company BioPhy, revealed how medicines are labeled.
The Philadelphia-based doctor, formerly the AI drug development lead at Johnson & Johnson, said that he, too, at first questioned, “How do they even come up with these [names]?”
